fibroblast activation protein
Showing 1 - 25 of >10,000
Fibroblast Activation Protein Inhibitor PET/CT Imaging in
Recruiting
- Gastrointestinal Cancer
- Fibroblast activation protein inhibitor PET/CT imaging
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Jul 14, 2022
Cancer, Peritoneal Carcinomatosis Trial in Brussels (FAPI PET/CT)
Recruiting
- Cancer
- Peritoneal Carcinomatosis
- FAPI PET/CT
-
Brussels, BelgiumInstitut Jules Bordet
Sep 25, 2023
Psoriatic Arthritis Trial in Beijing (68Ga-FAPI)
Recruiting
- Psoriatic Arthritis
-
Beijing, Beijing, ChinaChinese Academy of Medical Sciences & Peking Union Medical Colle
Jan 7, 2023
Breast Tumors Trial
Not yet recruiting
- Breast Tumors
- (no location specified)
Aug 2, 2023
Malignant Tumor, Positron Emission Tomography, Fibroblast Activation Protein Inhibitor Trial in Beijing (68Ga-TCR-FAPI PET/CT)
Recruiting
- Malignant Tumor
- +2 more
- 68Ga-TCR-FAPI PET/CT
-
Beijing, ChinaPeking University Cancer Hospital
Oct 19, 2023
Malignant Tumor Trial in Wuhan (68Ga-DOTA-FAPI, PET/MR, PET/CT)
Recruiting
- Malignant Neoplasm
- 68Ga-DOTA-FAPI
- +2 more
-
Wuhan, Hubei, ChinaChina, Hubei Province
Feb 9, 2022
Tumors Trial in Chengdu
Recruiting
- Neoplasms
-
Chengdu, Sichuan, ChinaDepartments of Nuclear Medicine, Sichuan Provincial People's Hos
Oct 16, 2023
Liver Fibrosis, Positron Emission Tomography, Magnetic Resonance Imaging Trial in Wuhan (PET/MR, PET/CT)
Recruiting
- Liver Fibrosis
- +2 more
- PET/MR
- PET/CT
-
Wuhan, Hubei, ChinaChina, Hubei Province
Feb 8, 2022
Solid Tumor, Unspecified, Adult Trial in Meldola (68 Gallium -Fibroblast Activating Protein Inhibitor -46 Positron emission
Recruiting
- Solid Tumor, Unspecified, Adult
- 68 Gallium -Fibroblast Activating Protein Inhibitor -46 Positron emission tomography / Computerized tomography
-
Meldola, Forlì Cesena, ItalyIRCCS Istituto ROmagnolo per lo Studio dei Tumori "Dino Amadori"
Nov 15, 2023
Cancer Trial in Stanford (68Ga-FAPI, Computed Tomography (CT) scan, Positron Emission Tomography (PET) scan)
Not yet recruiting
- Cancer
- 68Ga-FAPI
- +2 more
-
Stanford, CaliforniaStanford University Hospitals and Clinics
Nov 9, 2022
Lupus Nephritis Trial in Shanghai (68Ga-FAPI-04 PET)
Recruiting
- Lupus Nephritis
- 68Ga-FAPI-04 PET
-
Shanghai, ChinaRuijin Hospital
May 4, 2023
Tumor, Solid Trial in Beijing (68Ga-DOTA-F2 PET/CT and 18F-FDG)
Recruiting
- Tumor, Solid
- 68Ga-DOTA-F2 PET/CT and 18F-FDG
-
Beijing, Beijing, ChinaPeking union medical college hospital
Nov 27, 2022
Solid Tumor, Unspecified, Adult Trial in Singapore (177Lu-LNC1004 Injection group 1 radionuclide therapy, 177Lu-LNC1004
Not yet recruiting
- Solid Tumor, Unspecified, Adult
- 177Lu-LNC1004 Injection group 1 radionuclide therapy
- +3 more
-
Singapore, SingaporeNational University Cancer Institute, Singapore National Univers
Feb 1, 2023
Fibroblast Activation Protein Inhibitor, PET/CT, Malignant Tumor Trial in Wuhan (68Ga-FAPI, PET/CT)
Recruiting
- Fibroblast Activation Protein Inhibitor
- +2 more
- 68Ga-FAPI
- PET/CT
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Aug 27, 2021
Advanced Malignant Solid Tumor Trial in France, Netherlands (MP0317, a tri-specific fibroblast activation protein (FAP) x CD40
Recruiting
- Advanced Malignant Solid Tumor
- MP0317, a tri-specific fibroblast activation protein (FAP) x CD40 DARPin® drug candidate
-
Lyon, Cedex 08, France
- +3 more
Nov 4, 2022
Refractory Thyroid Gland Carcinoma, Refractory Thyroid Gland Papillary Carcinoma, Refractory Thyroid Gland Follicular Carcinoma
Recruiting
- Refractory Thyroid Gland Carcinoma
- +3 more
- 177Lu-DOTA-EB-FAPI 1 radionuclide therapy
- +2 more
-
Xiamen, ChinaThe First Affiliated Hospital of Xiamen University
Nov 3, 2022
Breast Tumors, Positron Emission Tomography, Fibroblast Activation Protein Inhibitor Trial in Baku (68Ga-FAPI-46 PET/CT)
Recruiting
- Breast Neoplasms
- +3 more
- 68Ga-FAPI-46 PET/CT
-
Baku, AzerbaijanNational Centre of Oncology
Jun 21, 2022
Liver Fibrosis, Pulmonary Fibrosis, Myocardial Fibrosis Trial in San Francisco (68Ga-FAP-2286, Positron Emission Tomography
Recruiting
- Liver Fibrosis
- +2 more
- 68Ga-FAP-2286
- Positron Emission Tomography (PET)
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jan 5, 2022
Advanced Solid Tumor Trial in Spain, United States (OMTX705, Pembrolizumab)
Not yet recruiting
- Advanced Solid Tumor
-
Boston, Massachusetts
- +7 more
Sep 16, 2022
PET/CT, FAPI, Oral Cancer Trial in Wuhan (68Ga-DOTA-FAPI, PET/CT)
Recruiting
- PET/CT
- +2 more
- 68Ga-DOTA-FAPI
- PET/CT
-
Wuhan, Hubei, ChinaZhongnan Hopital of Wuhan University
Dec 30, 2021
Pancreatic Tumors, Stomach Tumors, Bile Duct Tumors Trial in Stockholm (68Ga-FAPI-46, PET/CT)
Recruiting
- Pancreatic Neoplasms
- +3 more
- 68Ga-FAPI-46
- PET/CT
-
Stockholm, SwedenKarolinska University Hospital Huddinge
Dec 13, 2021
Metastatic Colorectal Cancer Trial in Worldwide (RO7122290, Cibisatamab, Obinutuzumab)
Recruiting
- Metastatic Colorectal Cancer
- RO7122290
- +2 more
-
Toronto, Ontario, Canada
- +15 more
Jan 13, 2023
The Role of Fibroblast Activation in Uterine Fibroid
Completed
- Uterine Fibroid
- Measurement of protein expression in tissues.
-
Assiut, EgyptAssiut university -Faculty of medicine- Departement of Biochemis
Feb 5, 2021
Myocardial Remodeling After AMI Trial in Shanghai (68Ga-FAPI PET/MRI)
Completed
- Myocardial Remodeling After AMI
- 68Ga-FAPI PET/MRI
-
Shanghai, ChinaShanghai Ruijin Hospital
Oct 23, 2022